
Jonathan Gardner
Senior Reporter | @ByJonGardner726 articles by Jonathan Gardner
-
After years of disappointment, cancer vaccines show new promise
June 8, 2023 -
Closing ASCO: AstraZeneca’s ‘very special’ meeting, more CAR-T survival data and Pfizer’s PARP play
June 6, 2023 -
Novartis drug helps stop breast cancer’s return in large study
June 2, 2023 -
Pfizer says hemophilia drug succeeded in Phase 3 study
May 30, 2023 -
J&J antibody drug combination shows promise in multiple myeloma
May 25, 2023 -
Teva puts rival to Prometheus, Pfizer drugs at center of turnaround plans
May 18, 2023 -
FTC sues to block Amgen’s $27.8B deal for Horizon
May 16, 2023 -
Gilead expands Arcus partnership, with eye to inflammatory disease
May 15, 2023 -
Cancer vaccine from BioNTech, Roche shows potential in small study
May 10, 2023 -
Roche pays China-based biotech $70M for a new HER2 drug
May 9, 2023 -
FibroGen’s anemia pill falls short in blood cancer study
May 5, 2023 -
Novo reveals another setback in obesity drug’s launch
May 4, 2023 -
Lilly’s fortunes rise on back-to-back success for Alzheimer’s, obesity drugs
May 4, 2023 -
Lilly drug slows Alzheimer’s decline in large study
May 3, 2023 -
Pfizer turns focus to new drugs as COVID vaccine revenue falls
May 2, 2023 -
Lilly plans dash to market for weight loss drug after trial win
April 27, 2023 -
Lilly drug Mounjaro succeeds in second weight loss study
April 27, 2023 -
Bristol Myers’ Caforio stepping down as CEO in November
April 26, 2023 -
Roche’s new eye drug pressures Eylea with strong launch
April 26, 2023 -
Lilly sells emergency diabetes drug for $500M
April 24, 2023 -
French biotech pulls EMA application for eye disease gene therapy
April 21, 2023 -
FDA approves earlier use of Roche’s Polivy in common form of lymphoma
April 20, 2023 -
Nektar lays off more staff in effort to sustain operations
April 18, 2023 -
Moderna, Merck data support claim of cancer vaccine’s promise
April 16, 2023 -
FDA again knocks back Alvotech’s Humira biosimilar
April 14, 2023